People: Accelerate Diagnostics Inc (AXDX.O)

AXDX.O on Consolidated Issue listed on NASDAQ Capital Market

20.40USD
23 Jan 2015
Change (% chg)

$-0.94 (-4.40%)
Prev Close
$21.34
Open
$21.30
Day's High
$21.56
Day's Low
$20.35
Volume
57,023
Avg. Vol
158,540
52-wk High
$31.86
52-wk Low
$12.50

Search Stocks

Reichling, Steve 

Brief Biography

Mr. Steve Reichling is Chief Financial Officer of Accelerate Diagnostics Inc., since September 10, 2012. Prior to joining the Company, Mr. Reichling served as general manager of Spring Bioscience Corp., a R&D and research products subsidiary of Roche Tissue Diagnostics. From January 2003 to December 2009, Mr. Reichling held various finance, accounting and operations leadership roles at Roche Tissue Diagnostics and Ventana Medical Systems, Inc., including director of finance and operations, manager of business development finance, and head of Internal Audit and Sarbanes Oxley Compliance. From October 2002 to January 2003, Mr. Reichling was an auditor at Ernst & Young LLP. Mr. Reichling received his B.A. in accounting and entrepreneurship from the University of Arizona and is a Certified Public Accountant.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
222,164 -- 368,238 590,402

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Patience

--

Lawrence Mehren

429,690

Steve Reichling

590,402

Pete Bantock

1,369,580

Mark Miller

--

Jack Schuler

--
As Of 30 Dec 2013
Search Stocks